911196-29-7 Usage
Chemical compound
A derivative of ractopamine, a beta-adrenergic agonist.
Use in animal husbandry
Commonly used as a feed additive to promote lean muscle growth in food-producing animals.
Potential use
Studied for its potential as a performance-enhancing drug in athletic and bodybuilding contexts.
Effects
Believed to have similar effects to ractopamine in promoting muscle growth and reducing fat deposition.
Pharmacokinetics
May have potential modifications to its pharmacokinetics compared to ractopamine.
Potency
May have different potency levels compared to ractopamine.
Safety concerns
Due to potential safety concerns, its use remains controversial.
Regulatory restrictions
Regulatory restrictions on the use of ractopamine in food-producing animals may also apply to this derivative.
Further research
Subject to further research and regulatory evaluation to determine its safety and efficacy.
Legal status
The use of this derivative in any form is controversial and may be subject to legal restrictions depending on the jurisdiction.
Check Digit Verification of cas no
The CAS Registry Mumber 911196-29-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,1,1,9 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 911196-29:
(8*9)+(7*1)+(6*1)+(5*1)+(4*9)+(3*6)+(2*2)+(1*9)=157
157 % 10 = 7
So 911196-29-7 is a valid CAS Registry Number.
911196-29-7Relevant academic research and scientific papers
Phenethanolamine-derived haptens, immunogens and conjugates comprising them and antibodies recognising said immunogenes and conjugates
-
Page/Page column 10; 22, (2010/11/08)
The present invention relates to a method for preparing haptens of formulae I and II that are useful in the preparation of immunogens, antibodies and conjugates, for use in competitive immunoassays for the detection of ractopamine, isoxsuprine and ritodrine. The haptens are prepared by reacting a phenylethanolamine derivative of formula D with a phenylalkylcarbonyl derivative of formula E: in which, in formula I, Z1 is a crosslinker and Z2 is H and, in formula II, Z1 is H and Z2 is a crosslinker.
